Vir Biotechnology, Inc. VIR Unrealized Losses on Investments (Before Tax)
Unrealized Losses on Investments (Before Tax) at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s unrealized losses on investments (before tax).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s unrealized losses on investments (before tax)?
- Vir Biotechnology, Inc. (VIR) reported unrealized losses on investments (before tax) of $685K in Q1 2026.
- How has Vir Biotechnology, Inc.'s unrealized losses on investments (before tax) changed year-over-year?
- Vir Biotechnology, Inc.'s unrealized losses on investments (before tax) increased by 1493.0% year-over-year, from $43K to $685K.
- What is the long-term trend for Vir Biotechnology, Inc.'s unrealized losses on investments (before tax)?
- Over 2 years (2023 to 2025), Vir Biotechnology, Inc.'s unrealized losses on investments (before tax) has grown at a -60.8% compound annual growth rate (CAGR), from $130K to $20K.